Literature DB >> 1745362

HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord.

A I Bhigjee1, C A Wiley, W Wachsman, T Amenomori, D Pirie, P L Bill, I Windsor.   

Abstract

A 49-year-old South African man developed a rapidly progressive myelopathy 14 months after blood transfusion and died 1 year after the onset of symptoms. Detailed pathologic examination of the spinal cord was consistent with the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although no HTLV-I viral particles, antigens, or nucleic acids were detected in situ, polymerase chain reaction assays revealed HTLV-I proviral DNA in cervical, thoracic, and lumbar levels of the spinal cord, with the greatest amount being detected at the thoracic level. These findings suggest that the pathogenesis of HAM/TSP depends on direct infection of neural or immune elements within the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1745362     DOI: 10.1212/wnl.41.12.1990

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV.

Authors:  R P Lopes; M Menna-Barreto; M E Bauer
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 2.  Artificial hydration and alimentation at the end of life: a reply to Craig.

Authors:  M Ashby; B Stoffell
Journal:  J Med Ethics       Date:  1995-06       Impact factor: 2.903

3.  Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM).

Authors:  A Yoshioka; G Hirose; Y Ueda; Y Nishimura; K Sakai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

4.  Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.

Authors:  I A Romero; M C Prevost; E Perret; P Adamson; J Greenwood; P O Couraud; S Ozden
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes.

Authors:  M Tillmann; R Wessner; B Wigdahl
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.

Authors:  S Kushida; H Mizusawa; M Matsumura; H Tanaka; Y Ami; M Hori; K Yagami; T Kameyama; Y Tanaka; A Yoshida
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

Authors:  P M Hoffman; S Dhib-Jalbut; J A Mikovits; D S Robbins; A L Wolf; G K Bergey; N C Lohrey; O S Weislow; F W Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Nontraumatic Myelopathy in Malawi: A Prospective Study in an Area with High HIV Prevalence.

Authors:  Eduard E Zijlstra; Jaap J van Hellemond; Arthur D Moes; Christa de Boer; Shelley A Boeschoten; Catharina E M van Blijswijk; Roos M van der Vuurst de Vries; Peter A B Bailey; Sam Kampondeni; Lisette van Lieshout; Saskia L Smits; Juri Katchanov; Nyengo M Mkandawire; Camilla Rothe
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

10.  Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.

Authors:  T J Lehky; E P Cowan; L A Lampson; S Jacobson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.